# Takeda Pharmaceutical Company Limited: business model and financials

> Latest period: FY ending Mar 2024, consolidated, IFRS
> Unit: JPY millions
> Sources: 有価証券報告書－第149期(2025/04/01－2026/03/31) (S100YB5L)
> Page: https://vizora.meequs.com/en/company/takeda-pharmaceutical
> Retrieved: 2026-09-30T20:26:29.101Z

## Company

Takeda, founded in 2024, is a company in Pharmaceuticals listed on TSE Prime. It has 49,281 employees (consolidated).

| Field | Value |
| --- | ---: |
| Legal name | Takeda Pharmaceutical Company Limited |
| Ticker | 4502 |
| Stock price | View on Yahoo Finance (https://finance.yahoo.co.jp/quote/4502.T) |
| Listing | TSE Prime |
| Head office | 大阪府大阪市中央区道修町四丁目1番1号(上記は登記上の本店所在地で実際の業務は「最寄りの連絡場所」で行っております。) |
| Representative (per filing) | 代表取締役社長CEO クリストフ ウェバー |
| Founded | Jul 2024 |
| Employees (consolidated) | 49,281 |
| Fiscal year end | March |
| Website | www.takeda.com (https://www.takeda.com/) |
| Corporate number | 2120001077461 |
| EDINET | E00919 |
| Industries (Vizora) | Pharmaceuticals |

> Profile source: annual securities report (S100YB5L, filed 2026-06-17). As of filing

## Five-axis industry profile

Primary industry: Pharmaceuticals (2024-03-31)

| Axis | Industry percentile | Peers |
| --- | ---: | ---: |
| Efficiency | 1.6 | 32 |

Each axis is shown independently. Missing values are labeled unavailable; no combined score is calculated. Industry rank is not an investment recommendation.

## Key points (generated from figures)

- Takeda brought in ¥4.26T in revenue.
- Revenue changed +5.9% from the prior year.

## Key figures at a glance

| Metric | Value | Note |
| --- | ---: | ---: |
| Revenue | ¥4.26T |  |
| Operating income | — | Margin — |
| Net income | ¥144.1B | Margin 3.4% |
| Free cash flow | — |  |
| Employees (consolidated) | 49,281 |  |
| Cash ratio | 3.0% | Cash ÷ revenue 10.7% |
| ROE | 2.0% | Equity approximated |
| ROA | 1.0% | Derived from disclosed figures |

## Notable figures

- FY2024, operating cash flow is 5.0× net income
- FY2024, cash is 3% of total assets

## What changed in 7 years

| Metric | FY ending Mar 2017 | FY ending Mar 2024 | Change |
| --- | ---: | ---: | ---: |
| Revenue | ¥1732051000000 | ¥4263762000000 | +146.2% |
| Employees | 29,900 people | 49,281 people | +64.8% |
| Cash and equivalents | ¥319455000000 | ¥457800000000 | +43.3% |

### Change in segment revenue mix

Span: FY ending Mar 2017 → FY ending Mar 2024. Stable segment keys are connected; unmatched shares are marked as new or reorganized. Shares use total segment revenue.

## Income statement（FY ending Mar 2024, consolidated, IFRS）

| Item | Amount (JPY mn) | % of revenue | Source |
| --- | ---: | ---: | ---: |
| Revenue | 4,263,762 | 100.0% | S100YB5L |
| Pretax income | 52,791 | 1.2% | S100YB5L |
| Net income | 144,197 | 3.4% | S100YB5L |
| Net income attributable to owners | 144,067 | 3.4% | S100YB5L |

A machine-readable operating income value exists, but it is not in the validated published data, so the chart is omitted.

## Year over year（FY ending Mar 2023 → FY ending Mar 2024、JPY mn）

| Metric | Prior | Current | Change | % change |
| --- | ---: | ---: | ---: | ---: |
| Revenue | 4,027,478 | 4,263,762 | 236,284 | +5.9% |
| Net income attributable to owners | 317,017 | 144,067 | -172,950 | -54.6% |
| Operating cash flow | 977,156 | 716,344 | -260,812 | -26.7% |

## History（JPY mn）

| Period | Revenue | Op. income | Op. margin | Net income | Op. CF | FCF | Source |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| FY ending Mar 2017 | 1,732,051 | — | — | 114,940 | 261,363 | — | S100LR7D |
| FY ending Mar 2018 | 1,770,531 | — | — | 186,886 | 377,854 | — | S100OBQE |
| FY ending Mar 2019 | 2,097,224 | — | — | 135,192 | 328,479 | — | S100R3K7 |
| FY ending Mar 2022 | 3,569,006 | — | — | 230,059 | 1,123,105 | — | S100YB5L |
| FY ending Mar 2023 | 4,027,478 | — | — | 317,017 | 977,156 | — | S100YB5L |
| FY ending Mar 2024 | 4,263,762 | — | — | 144,067 | 716,344 | — | S100YB5L |

## People and productivity（FY ending Mar 2024, consolidated, IFRS）

| Metric | Value |
| --- | ---: |
| Revenue per employee (consolidated) | ¥86.5M |
| Net income per employee (consolidated) | ¥2.9M |

Employees, revenue and profit are consolidated. Average annual salary is a separate parent-company figure. Calculated from disclosed figures (DERIVED).

| History | FY ending Mar 2018 | FY ending Mar 2019 | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 |
| --- | ---: | ---: | ---: | ---: | ---: |
| Employees (consolidated) | 27,230 | 49,578 | 47,347 | 49,095 | 49,281 |
| Average salary (parent company) | — | — | — | — | — |
| Average age (parent company) | — | — | — | — | — |
| Average tenure (parent company) | — | — | — | — | — |

Year over year: Employees (consolidated) +0.4% · Revenue (consolidated) +5.9%

## Revenue by geography

No geographic revenue breakdown was disclosed.

## Cash flow（FY ending Mar 2024, consolidated, IFRS）

| Item | Amount (JPY mn) | % of revenue | Source |
| --- | ---: | ---: | ---: |
| Operating cash flow | 716,344 | 16.8% | S100YB5L |
| Investing cash flow | -463,862 | -10.9% | S100YB5L |
| Financing cash flow | -354,416 | -8.3% | S100YB5L |
| Change in cash | -101,934 | -2.4% | 算出 |
| Cash and equivalents | 457,800 | 10.7% | S100YB5L |

## Balance sheet

Figures are as of each fiscal year end. Derived values are marked as such in the source column. Lease liabilities are excluded from interest-bearing debt.

| Metric | FY ending Mar 2018 | FY ending Mar 2019 | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | Source |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | 294,522 | 702,093 | 849,695 | 533,530 | 457,800 | S100OBQE, S100LR7D, S100YB5L |
| Total assets | 4,106,463 | 13,792,773 | 13,178,018 | 13,957,750 | 15,108,792 | S100OBQE, S100R3K7, S100YB5L |
| Net assets | — | 5,185,991 | — | — | 7,274,005 | S100LR7D, S100YB5L |

### Balance sheet history

| Metric | FY ending Mar 2018 | FY ending Mar 2019 | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 |
| --- | ---: | ---: | ---: | ---: | ---: |
| Total assets | 4,106,463 | 13,792,773 | 13,178,018 | 13,957,750 | 15,108,792 |
| Equity | — | 5,185,991 | — | — | 7,274,005 |
| Interest-bearing debt | — | — | — | — | — |
| Cash | 294,522 | 702,093 | 849,695 | 533,530 | 457,800 |

### Cash quality

Net cash = cash − interest-bearing debt. Net debt ratio = (interest-bearing debt − cash) ÷ positive operating cash flow. Omit when debt components are incomplete; other ratios are derived from reported figures.

| Metric | Value |
| --- | ---: |
| Cash ratio (cash ÷ total assets) | 3.0% |
| Cash ÷ revenue | 10.7% |
| Net cash (cash − interest-bearing debt) | — |
| Net debt ÷ operating cash flow | — |
| Cash conversion (operating CF ÷ operating income) | — |
| Cash vs. profit gap | 572,277 JPY mn (of net income 397.2%) |
| Shareholder returns / net income | — |
| Shareholder returns / FCF | — |
| Shareholder payments — dividends / net income | — |
| Shareholder payments — dividends / FCF | — |
| CapEx intensity (capex ÷ revenue) | — |
| Investing CF relative to operating CF | 64.8% |

## ROA and ROE

ROE is decomposed into net margin × asset turnover × financial leverage. Leverage can raise ROE, so the ratio alone does not assess a company's condition. Ending balances are used without a prior year; total equity approximates parent equity when unavailable.

| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE | Sources |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| 2018 | — | —× | 4.6% | —× | — | S100OBQE |
| 2019 | 6.4% | 0.23× | 1.5% | 1.73× | 2.6% | S100R3K7, S100LR7D |
| 2022 | — | —× | 1.7% | —× | — | S100YB5L |
| 2023 | — | —× | 2.3% | —× | — | S100YB5L |
| 2024 | 3.4% | 0.29× | 1.0% | 2.00× | 2.0% | S100YB5L |

## Ownership

| Counterparty | Relation | Ratio | As of |
| --- | ---: | ---: | ---: |
| 日本マスタートラスト信託銀行株式会社（信託口） | Major shareholder | 16.8% | 2026-03-31 |
| 株式会社日本カストディ銀行（信託口） | Major shareholder | 5.4% | 2026-03-31 |
| THE BANK OF NEW YORK MELLON AS DEPOSITARY BANK FOR DEPOSITARY RECEIPT HOLDERS（常任代理人 株式会社三井住友銀行） | Major shareholder | 4.5% | 2026-03-31 |
| STATE STREET BANK AND TRUST COMPANY 505001 （常任代理人 株式会社みずほ銀行決済営業部） | Major shareholder | 2.9% | 2026-03-31 |
| THE CHASE MANHATTAN BANK, N.A. LONDON SECS LENDING OMNIBUS ACCOUNT（常任代理人 株式会社みずほ銀行決済営業部） | Major shareholder | 2.4% | 2026-03-31 |
| JP MORGAN CHASE BANK 385642（常任代理人 株式会社みずほ銀行決済営業部） | Major shareholder | 1.5% | 2026-03-31 |
| JP MORGAN CHASE BANK 385781（常任代理人 株式会社みずほ銀行決済営業部） | Major shareholder | 1.5% | 2026-03-31 |
| SMBC日興証券株式会社 | Major shareholder | 1.4% | 2026-03-31 |
| JPモルガン証券株式会社 | Major shareholder | 1.3% | 2026-03-31 |
| バークレイズ証券株式会社 | Major shareholder | 1.2% | 2026-03-31 |

## Sources

| Document | ID | Published | URL |
| --- | ---: | ---: | ---: |
| 有価証券報告書－第149期(2025/04/01－2026/03/31) | S100YB5L | 2026-06-17 | https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YB5L,, |
| 有価証券報告書－第146期(2022/04/01－2023/03/31) | S100R3K7 | 2023-06-28 | https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100R3K7,, |
| 有価証券報告書－第145期(令和3年4月1日－令和4年3月31日) | S100OBQE | 2022-06-29 | https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100OBQE,, |
| 有価証券報告書－第144期(令和2年4月1日－令和3年3月31日) | S100LR7D | 2021-06-29 | https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100LR7D,, |

## Key alliances (from the filing's material contracts)

| Partner | Type | Description | Source |
| --- | ---: | ---: | ---: |
| 大塚ホールディングス | Alliance | 大塚製薬が武田薬品の「タケキャブ錠」を国内で共同プロモーション | S100XUA7 |

## Definitions

- Amounts are in millions of JPY (rounded). The period is stated in each table heading
- Operating margin = operating income ÷ revenue. Net income is attributable to owners of the parent when disclosed
- Free cash flow (FCF) = operating cash flow − capital expenditure
- ¥100 model = breakdown per ¥100 of revenue (rounded so parts sum to 100)
- Segment revenues include inter-segment sales and may not sum to consolidated revenue
- Source IDs are EDINET document IDs (docID). "算出" (derived) means computed from other disclosed values
- All figures are extracted mechanically from filings. AI-written text never generates figures
- Source: company filings submitted to EDINET (Financial Services Agency of Japan). Figures were extracted, edited and processed, and charts and text were created, by Vizora — not by the FSA (used under the Public Data License v1.0).